We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Gives Trial Advice for Bacterial Vaginosis Drugs
FDA Guidance Gives Trial Advice for Bacterial Vaginosis Drugs
The FDA is recommending that companies conducting clinical trials on bacterial vaginosis drugs exclude patients with herpes simplex or human papilloma virus, one of dozens of recommendations the agency made on the subject Thursday.